155 related articles for article (PubMed ID: 26344588)
21. Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells.
Chen Y; Zhou Q; Zhang L; Wang R; Jin M; Qiu Y; Kong D
Oncol Rep; 2016 Dec; 36(6):3643-3650. PubMed ID: 27748929
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines.
Kamal A; Ramakrishna G; Raju P; Rao AV; Viswanath A; Nayak VL; Ramakrishna S
Eur J Med Chem; 2011 Jun; 46(6):2427-35. PubMed ID: 21481986
[TBL] [Abstract][Full Text] [Related]
23. Antiproliferative activities of a library of hybrids between indanones and HDAC inhibitor SAHA and MS-275 analogues.
Charrier C; Roche J; Gesson JP; Bertrand P
Bioorg Med Chem Lett; 2007 Nov; 17(22):6142-6. PubMed ID: 17897824
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of 4'-O-alkylamino-tethered-benzylideneindolin-2-ones as potent cytotoxic and apoptosis inducing agents.
Senwar KR; Reddy TS; Thummuri D; Sharma P; Bharghava SK; Naidu VG; Shankaraiah N
Bioorg Med Chem Lett; 2016 Aug; 26(16):4061-9. PubMed ID: 27397498
[TBL] [Abstract][Full Text] [Related]
25. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
Zhou P; Huang L; Zhou J; Jiang B; Zhao Y; Deng X; Zhao Q; Li F
Bioorg Med Chem Lett; 2017 Sep; 27(17):4185-4189. PubMed ID: 28757067
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of 4-(acylaminomethyl)benzamides and their evaluation as potential anticancer agents.
Schlitzer M; Sattler I; Friese A; Zündorf I; Dingermann T
Anticancer Res; 2000; 20(3A):1723-6. PubMed ID: 10928099
[TBL] [Abstract][Full Text] [Related]
27. ABT-263 induces G
Lin QH; Que FC; Gu CP; Zhong DS; Zhou D; Kong Y; Yu L; Liu SW
Acta Pharmacol Sin; 2017 Dec; 38(12):1632-1641. PubMed ID: 28713162
[TBL] [Abstract][Full Text] [Related]
28. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
29. Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562).
Joshi H; Marulkar K; Gota V; Ramaa CS
Anticancer Agents Med Chem; 2017; 17(4):524-541. PubMed ID: 27291250
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and structure-activity relationship of N-(piperidin-4-yl)benzamide derivatives as activators of hypoxia-inducible factor 1 pathways.
Huang ZN; Liang H; Qiao H; Wang BR; Qu N; Li H; Zhou RR; Wang LJ; Li SH; Li FN
Arch Pharm Res; 2018 Dec; 41(12):1149-1161. PubMed ID: 29998374
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
[TBL] [Abstract][Full Text] [Related]
32. BJ-B11, a novel Hsp90 inhibitor, induces apoptosis in human chronic myeloid leukemia K562 cells through the mitochondria-dependent pathway.
Ju HQ; Wang SX; Xiang YF; Liu Z; Liu JY; Chen ZP; Zeng FL; Xia M; Liu ZH; Xing GW; Wang SY; Wang YF
Eur J Pharmacol; 2011 Sep; 666(1-3):26-34. PubMed ID: 21620825
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents.
Hisham M; Youssif BGM; Osman EEA; Hayallah AM; Abdel-Aziz M
Eur J Med Chem; 2019 Aug; 176():117-128. PubMed ID: 31108261
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of substituted 3-amino-N-phenyl-1H-indazole-1-carboxamides endowed with antiproliferative activity.
Maggio B; Raimondi MV; Raffa D; Plescia F; Cascioferro S; Plescia S; Tolomeo M; Di Cristina A; Pipitone RM; Grimaudo S; Daidone G
Eur J Med Chem; 2011 Jan; 46(1):168-74. PubMed ID: 21130540
[TBL] [Abstract][Full Text] [Related]
35. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antiproliferative and apoptosis-inducing activity of novel 3-substituted-3-hydroxy-2-oxindole compounds.
Nazemi Moghaddam M; Jalal R; Zeraatkar Z
In Vitro Cell Dev Biol Anim; 2018 Jan; 54(1):61-70. PubMed ID: 29124512
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of thiobenzanilides as anticancer agents.
Hu WP; Yu HS; Chen YR; Tsai YM; Chen YK; Liao CC; Chang LS; Wang JJ
Bioorg Med Chem; 2008 May; 16(9):5295-302. PubMed ID: 18359635
[TBL] [Abstract][Full Text] [Related]
38. In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition.
Balachandran C; Emi N; Arun Y; Yamamoto N; Duraipandiyan V; Inaguma Y; Okamoto A; Ignacimuthu S; Al-Dhabi NA; Perumal PT
Chem Biol Interact; 2016 Apr; 249():23-35. PubMed ID: 26915975
[TBL] [Abstract][Full Text] [Related]
39. Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with Imatinib.
Joshi H; Patil V; Tilekar K; Upadhyay N; Gota V; Ramaa CS
Bioorg Med Chem Lett; 2020 Dec; 30(23):127561. PubMed ID: 32961322
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of 4-bromo-N-(3,5-dimethoxyphenyl)benzamide derivatives as novel FGFR1 inhibitors for treatment of non-small cell lung cancer.
Xie Z; Cheng D; Luo L; Shen G; Pan S; Pan Y; Chen B; Wang X; Liu Z; Zhang Y; Ye F
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):905-919. PubMed ID: 29734851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
